CNIO - Spanish National Cancer Research Centre
Lydia Thelma Poluha is a dedicated researcher currently serving as a PhD student at the Melanoma Lab of the CNIO - Spanish National Cancer Research Centre since April 2021. Lydia's research focuses on the immune system's role in obesity and metabolic syndrome, including the investigation of the Aim2 inflammasome in mice fed a high-fat diet. Prior to this role, Lydia held positions as a pre-doctoral research assistant, master's student, and undergraduate research assistant at various institutions, including the CNIO and The University of Salford, where projects involved studying exosomes related to Echinococcus infections and the mTOR pathway in telomere-shortened mice. Lydia holds a master's degree in Molecular Biomedicine from Universidad Autónoma de Madrid and a degree in Human Biology and Infectious Diseases from The University of Salford.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.